Stock Information

View Detailed Stock Information

Stock Snapshot for NYSE: BDX

Detailed Stock Information
View Quarterly Earnings

Quarterly Earnings
View Events

Events
View News Releases

News Releases
View SEC Filings

SEC Filings
View ESG

ESG

About BD

BD is a global medical technology company that is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care.

70,000+

BD Associates

190+

Countries Served

34B+

Devices Made Annually

$1B+

Annual R&D Spending

33,000+

Active Patents

As of Jan 24, 2023 • Annual Meeting of Shareholders Presentation

For complete information regarding our financials, see our periodic filings

Upcoming Event

7th Annual Evercore ISI HealthCONx Conference
Add to Calendar View All Events

Latest Financial Results

Q4 FY24

Fiscal Year Ended Sep 30, 2024

$5.4B

Q4 2024 Total BD Revenue

$3.81

Q4 2024 Adjusted EPS*

Source: Q4 2024 Earning Press Release
* Non-GAAP Financial Measures. View full reconciliation in our Q3 earnings press release.

For complete information regarding our financials, see our periodic filings

Latest Annual Report

For Fiscal Year Ending Sep 30, 2023

View Report View 10-K

Latest News

First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities

View Press Release

BD to Present at the 7th Annual Evercore ISI HealthCONx Conference

View Press Release

BD Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

View Press Release
View All News

See How BD Solutions Advance Care Across The Patient Journey

Learn More

Together We Advance

Our ESG strategy—a four-pillar framework called Together We Advance—embraces the connections and interdependence between company health, planet health, community health and human health. Through this framework, we address the most relevant ESG issues for our business and stakeholders.

View ESG Efforts

Featured Reports

2023 Annual Report

2023 Annual Report

Download Report
2023 Sustainability Report

2023 Sustainability Report

Download Report
2022 Inclusion, Diversity and Equity Report

2022 Inclusion, Diversity and Equity Report

Download Report
2022 Cybersecurity Annual Report

2022 Cybersecurity Annual Report

Download Report

IR Contacts

Corporate Office

Becton, Dickinson and Company
1 Becton Drive
Franklin Lakes, NJ 07417
United States
800.284.6845

Investor Relations

Becton, Dickinson and Company
800.284.6845
investor_relations@bd.com

Transfer Agent

Computershare Trust Company, N.A.
P.O. Box 43006
Providence, RI 02940-3066
877.498.8861
computershare@computershare.com
https://www.computershare.com


Overnight Mail Address
150 Royall St., Suite 101
Canton, MA 02021